May 16, 2018
Inside Trading
TradeWins Publishing

Follow Us:



Other Exciting News

Chris Verhaegh

Join us for a FREE educational webinar with professional trader Chris Verhaegh TODAY, May 16th at 3:30pm Central Time.

Mining Silver (SLV) Options For Trading Profits

Chris will discuss his strategies to help you achieve the highest potential profits from mining silver options. Don't miss this great educational opportunity!

As a special bonus all attendees will receive a FREE giveaway courtesy of Chris.

Register Here Now
There's still time to join!

George Angell

One-time West Coast contributing editor of Futures Magazine, George Angell is the author of eight books on the futures and options markets, including Winning in the Futures Markets, which has been translated into Chinese, and is still in print 28 years after its first publication. He was a Chicago floor trader during the Eighties and credits that experience for the success of West of Wall Street, which he co-wrote with S&P pit trader Barry Haigh during his Chicago years, and Sniper Trading, which tracks the valuable lessons he learned while on the floor. In recent years, he has turned toward trading small stocks. 'There are enormous sums of money to be made trading undervalued small stocks,' says Angell, whose most recent two books - Small Stock, Big Profits and The 50 Best Small Stocks – have been highly acclaimed. A graduate of New York University, Angell currently resides in Key West, Florida which he considers the perfect antidote to the stress-filled years of the Chicago pit trader.

Putting A Spyglass On Profits


George Angell's market analysis and trading methods have generated over $1.5 MILLION in simulated trading profits in a single year.

How does he do it? One of his personal favorites is his SPYGLASS trading method, which attempts to predict market activity well in advance - often within three ticks and five minutes of a major move!

$727,825 IN PROFITS!!

In two separate simulated tests, the SPYGLASS method racked up day trading profits of more than $727,000 in less than a year.

Learn More About

Inside the Day Trading Game



Better Business Bureau

Better Business Bureau

Our Author Team
Click on authors name
to learn more


Nothing has the power to send a biotech stock to the moon like the FDA... unless that biotech is presenting at the annual American Society of Clinical Oncology (ASCO) conference. You see, any time a company is expected to present healthy data at ASCO, the speculation over FDA approval, buyout, and game-changing findings can jet stock prices going into the conference.

Even though the ASCO conference doesn't kick off for another couple of weeks, now is the perfect time to back up the truck. Here are five of our most favored stocks we believe could rally as we near presentations.

Next, Lee Gettess provides his perspective on both the S&P and the bond market for the coming week.

Then we bring you George Angell. In his article, George explains how to watch for hidden clues to determine the market’s trend.

Last, Chuck Hughes shares his Guaranteed Real Optioneering Winners - Optioneering Newsletter.


Adrienne LaVigne
TradeWins Publishing


ASCO 2018 Conference: One of the Greatest Catalysts for Biotechs

by Ian Cooper

Nothing has the power to send a biotech stock to the moon like the FDA...

...Unless that biotech is presenting at the annual American Society of Clinical Oncology (ASCO) conference. You see, any time a company is expected to present healthy data at ASCO, the speculation over FDA approval, buyout, and game-changing findings can jet stock prices going into the conference.

I expect this year's conference (taking place June 1st – 5th in Chicago) to be no different...

Even though the ASCO conference doesn't kick off for another couple of weeks, now is the perfect time to back up the truck.

Here are five of our most favored stocks we believe could rally as we near presentations.

Note: The best way to invest is to diversify with an equal amount in each position. Be sure to exit each on any run higher heading into the ASCO 2018 event. Typically, we will see a pullback in related names shortly after presentation.

ASCO 2018 Conference

Tomorrow, you could begin doubling your account every single month starting with one letter.

The letter will come from a 20-year trading professional named Ian Cooper. He says, “In 2017, following my trades you would be doubling even tripling your account some months. Let me show you how.”

He will show you exactly what to do... and he’ll give you the blueprint for just $1.

Click Here
Get all the details!


Lee Gettess' Market Sense

by Lee Gettess

Lee Gettess is a top trader who is excited to bring you his video newsletter. Each week, Lee will share his predictions on what he anticipates from the bond and S&P markets.

Watch Video


Day Trading: Follow the Trend

by George Angell

The following is an excerpt from George Angell's Inside The Day Trading Game

The more information you can gain from a market open, the better prepared you will be to make intelligent trading decisions during the day. Often, the open will provide a very valuable clue as to the day’s trend. Here, the indicators will be time and price. Put another way; is there sufficient volatility to suggest a genuine trend day? Or does the price action suggest a market which will simply meander? The answers to these questions are vital because they will determine whether you should be an aggressive trend follower or whether you should simply fade the trend.

How do you tell?

The key is early volatility. Does the market want to get somewhere in a hurry? Remember, you are monitoring both time and price. First, concern yourself with the question: does the market want to trend? Second, ask yourself if it does, in what direction? Here’s a general rule (no rule, remember, is 100% accurate), taking into account both time and price:

If the S&P futures move in excess of 100 points in the first 15 minutes of trading, following the open, chances favor a trend day. If the futures do not move in excess of 100 points within that time period, chances favor a non-trending day.

Follow the Trend


Guaranteed Real Optioneering Winners

by Chuck Hughes

Every week Chuck publishes his Optioneering Newsletter. The following is a trade opportunity taken from his most recent issue.

The first profit opportunity we will review this week is in LABU. LABU is the Direxion Daily S&P Biotech Bull 3X Shares ETF. LABU seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index.

The weekly chart shows that LABU has been in an uptrend since late 2016. Every swing low since then has made a higher low bottom. A new higher low bottom appears to be in place at this month’s low. Higher low bottoms point to higher high tops, so the next upside target is above this year’s high.

The daily chart shows that LABU has been bullish since the 2017 low. This week’s bullish trading suggests that the recent pullback could be over and the uptrend could be resuming. We are going to review a Call Debit Spread for LABU.

Traders who want more leverage can buy LABU calls. LABU has options expiring every week until June 29th. After that, LABU has options expiring in July, September, December, and January 2020. Click Here to follow this trade.

To Learn More Click Here


PLEASE READ: Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by TradeWins. For additional information on auto-trading, you may visit the SEC’s website: All About Auto-Trading, TradeWins does not recommend or refer subscribers to broker-dealers.  You should perform your own due diligence with respect to satisfactory broker-dealers and whether to open a brokerage account. You should always consult with your own professional advisers regarding equities and options on equities trading.

  1. The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the “Services”) is not customized or personalized to any particular risk profile or tolerance.  Nor is the information published by TradeWins Publishing (“TradeWins”) a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products.  The Services are intended to supplement your own research and analysis.

  2. TradeWins’ Services are not a solicitation or offer to buy or sell any financial products, and the Services are not intended to provide money management advice or services.

  3. Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk. Trading on margin carries a high level of risk, and may not be suitable for all investors.  Other than the refund policy detailed elsewhere, TradeWins does not make any guarantee or other promise as to any results that may be obtained from using the Services.  No person subscribing for the Services (“Subscriber”) should make any investment decision without first consulting his or her own personal financial adviser, broker or consultant. TradeWins disclaims any and all liability in the event anything contained in the Services proves to be inaccurate, incomplete or unreliable, or results in any investment or other loss by a Subscriber.

  4. You should trade or invest only “risk capital” – money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more.

  5. All investments carry risk and all trading decisions made by a person remain the responsibility of that person. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses. Subscribers should fully understand all risks associated with any kind of trading or investing before engaging in such activities.

  6. Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Simulated trading services in general are also designed with the benefit of hindsight, which may not be relevant to actual trading. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading.  TradeWins makes no representations or warranties that any account will or is likely to achieve profits similar to those shown.

  7. No representation is being made that you will achieve profits or the same results as any person providing testimonial.  No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have experienced losses.

  8. The author experiences are not typical.  The author is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position and other factors. Certain Subscribers may modify the author methods, or modify or ignore the rules or risk parameters, and any such actions are taken entirely at the Subscriber’s own election and for the Subscriber’s own risk.